Processing, please wait...

Panagiotis PEITSIDIS's informes (49)

Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence.

Dec, 2014

To conduct a detailed systematic review of the current evidence on the administration and efficacy of tranexamic acid in patients with menorrhagia due to uterine fibroids. leer más

World journal of clinical cases

Simultaneous Meckel's diverticulitis and appendicitis: a rare complication in puerperium.

Mar, 2013

We report a case of a 24-year-old woman who was delivered via cesarean section at 39 weeks and presented in the puerperium with symptoms of worsening abdominal pain and septicaemia. Preoperative ultrasonography suggested the presence of a pelvic collection. Explorative laparotomy revealed the simultaneous presence of Meckel's diverticulitis and appendicitis without bowel perforation. The patient made an uneventful recovery following small bowel resection with end to end reanastomosis and appendicectomy. leer más

Il Giornale di chirurgia

Ulipristal acetate and its role in emergency contraception: a comment.

Sep, 2012

The use of selective progesterone modulators (SRMs) has been investigated extensively over the last few years. Ulipristal acetate (UPA) is an selective progesterone receptor modulator (SPRM) which has been in use since 2010 as an effective alternative emergency contraception (EC) regimen to Levonorgestrel (LNG). It acts by inhibiting ovulation and delaying implantation. Its effectiveness is active up to 120 h after sexual intercourse. UPA is safe and has a good tolerability profile. Health care practitioners should inform women of all reproductive ages that UPA is an effective alternative agent for those who are dissatisfied with other means of EC, and its activity of up to 120 h after sexual intercourse should also be highlighted. leer más

Expert opinion on pharmacotherapy
Ver más  

conexiones de Panagiotis PEITSIDIS's (1)